First-line treatment of advanced breast cancer with sunitinib in combination with docetaxel versus docetaxel alone: Results of a prospective, randomized phase III study

QR Code

First-line treatment of advanced breast cancer with sunitinib in combination with docetaxel versus docetaxel alone: Results of a prospective, randomized phase III study

Bibliographic Details
Main Authors:	Bergh, J., Bondarenko, I., Lichinitser, M., Liljegren, A., Greil, R., Voytko, N., Makhson, A., Cortes, J., Lortholary, A., Bischoff, J., Chan, Arlene, Delaloge, S., Huang, X., Kern, K., Giorgetti, C.
Format:	Journal Article
Published:	American Society of Clinical Oncology 2012
Online Access:	http://hdl.handle.net/20.500.11937/17432

Similar Items

Phase III study of bevacizumab plus docetaxel compared with placebo plus docetaxel for the first-line treatment of human epidermal growth factor receptor 2-negative metastatic breast cancer
by: Miles, D., et al.
Published: (2010)

Vomiting in docetaxel chemotherapy: which to blame, dose or gene?
by: Jabir, Rafid, et al.
Published: (2014)

Biomarker results from the AVADO phase 3 trial of first-line bevacizumab plus docetaxel for HER2-negative metastatic breast cancer
by: Miles, D., et al.
Published: (2013)

Prevalence of Excessive Tearing in Women With Early Breast Cancer Receiving Adjuvant Docetaxel-Based Chemotherapy
by: Chan, Arlene, et al.
Published: (2013)

Biocompatible hyperbranched polyglycerol modified ß-cyclodextrin derivatives for docetaxel delivery
by: Xu, Z., et al.
Published: (2017)

Development and characterization of docetaxel and curcumin-loaded aerosolized nanoemulsion for pulmonary cancer
by: Asmawi, Azren Aida
Published: (2020)

Phase 1b dose-finding study of motesanib with docetaxel or paclitaxel in patients with metastatic breast cancer
by: De Boer, R., et al.
Published: (2012)

Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability
by: Badran, Mohamed M., et al.
Published: (2018)

Development and validation of HPLC method for quantification of docetaxel in palm-based nanoemulsion aerosols
by: Asmawi, Azren Aida, et al.
Published: (2020)

Nanostructured Lipid Carrier Co-Loaded with Docetaxel and Magnetic Nanoparticles: Physicochemical Characterization and In Vitro Evaluation
by: Auni Hamimi, Idris, et al.
Published: (2023)

Characterisation of tumorspheres generated from nasopharyngeal carcinoma cell line TW06 and chemoresistance to docetaxel
by: Goh, Iris Wen Li, et al.
Published: (2015)

In Vitro And In Vivo Toxicity Of Docetaxel-Loaded Polymeric Nanoparticles Formulation For Potential Treatment Of Lung Cancer
by: Ahmad Fisol, Faisalina
Published: (2022)

AVEREL: A Randomised Phase 111 Trial Evaluating Bevacizumab in Combination With Docetaxel and Trastuzumab As First-Line Therapy for HER-2Positive Locally Recurrent/Metastatic Breast Cancer
by: Gianni, L., et al.
Published: (2013)

Phase III study of doxorubicin/cyclophosphamide with concomitant versus sequential docetaxel as adjuvant treatment in patients with human epiderman growth factor receptor 2-normal, node-positive breast cancer: BCIRG-005 trial
by: Eiermann, W., et al.
Published: (2011)

Excipient selection and aerodynamic characterization of nebulized lipid-based nanoemulsion loaded with docetaxel for lung cancer treatment
by: Asmawi, Azren Aida, et al.
Published: (2019)

Characterization of tumorspheres generated from nasopharyngeal carcinoma cell line, TW06 and chemoresistance to docetaxel and oxaliplatin
by: Goh, Iris Wen Li, et al.
Published: (2015)

Characterization, histological evaluation and efficacy of docetaxel-loaded cockle shellderived CaCO3 nanoparticles in vitro and in vivo
by: Hammadi, Nahidah Ibrahim
Published: (2018)

Formulation of a sustained release docetaxel loaded cockle shell-derived calcium carbonate nanoparticles against breast cancer
by: Ibrahim Hammadi, Nahidah, et al.
Published: (2017)

Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized trial.
by: Mackey, J., et al.
Published: (2016)

Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial
by: Ford, Hugo, et al.
Published: (2014)

Star-Shaped Amphiphilic Hyperbranched Polyglycerol Conjugated with Dendritic Poly(l-lysine) for the Codelivery of Docetaxel and MMP-9 siRNA in Cancer Therapy.
by: Zhou, X., et al.
Published: (2016)

Health-related quality of life with adjuvant docetaxel- and trastuzumab-based regimens in patients with node-positive and high-risk node-negative, her2-positive early breast cancer: Results from the BCIRG 006 study
by: Au, H., et al.
Published: (2013)

The Effects of Combination Treatment Using Phenoxodiol and Docetaxel, and Phenoxodiol and Secreted Frizzled-related Protein 4 on Prostate Cancer Cell Lines
by: Mahoney, S., et al.
Published: (2014)

Development and characterization of a theranostic micelles system using TPGS with docetaxel and coumarin-6: a dual polymeric nanocarrier system
by: Ching, L.H., et al.
Published: (2018)

In vivo effects of sirolimus and sunitinib of breast cancer prognostic markers
by: Jaffar, Nurul Fathiyatul Nabila
Published: (2020)

Plasma alpha-1-acid glycoprotein as a potential predictive biomarker for non-haematological adverse events of docetaxel in breast cancer patients
by: Jabir, Rafid Salim, et al.
Published: (2018)

Docetaxel-loaded magnetic nanostructured lipid carrier functionalized with fish oil-coated iron oxide nanoparticles intended for lung cancer treatment
by: Idris, Auni Hamimi
Published: (2021)

Evaluation of in vitro efficacy of docetaxel-loaded calcium carbonate aragonite nanoparticles (DTX-CaCO3NP) on 4T1 mouse breast cancer cell line
by: Ibrahim Hammadi, Nahidah, et al.
Published: (2017)

Consuming Alone: Broadening Putnam's "Bowling Alone" Thesis
by: Rauch, A., et al.
Published: (2015)

Elucidating the effects of sirolimus and sunitinib on nmu-induced rat breast carcinoma: in vitro and in vivo studies
by: Sakri, Muhammad Shahidan Muhammad
Published: (2023)

Pharmacogenetics of CYP450A, ABCB1, ABCC2, SLCO1B3 gene polymorphisms and plasma alpha-1-acid glycoprotein level on nonhaematological adverse events of docetaxel in Malaysian breast cancer patients
by: Jabir, Rafid Salim
Published: (2015)

Randomized Phase 11 Study of the Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab With Cisplatin Versus Cisplatin Alone in Patients With Metastatis Triple-Negative Breast Cancer
by: Baselga, J., et al.
Published: (2013)

You can't solve homelessness through housing alone
by: McVilly, K., et al.
Published: (2017)

IRNSS stand-alone positioning: first results in Australia
by: Zaminpardaz, S., et al.
Published: (2016)

A tree alone
by: Majer, Jonathan, et al.
Published: (2000)

‘I’ve no fear of dying alone’: exploring perspectives on living and dying alone
by: Caswell, Glenys, et al.
Published: (2017)

The rate ratio of injury and aggressive incident for alcohol alone, cocaine alone and simultaneous use before the event: A case-crossover study
by: Zhao, J., et al.
Published: (2015)

Into the woods alone: Olga Cironis
by: Costantino, Thea
Published: (2013)

Leave Proton cars alone
Published: (2008)

Paper alone not enough : Salahuddin
by: The Borneo Post
Published: (2007)

Cannot write session to /tmp/vufind_sessions/sess_50p2j5gjuqff8nn4sk5hgs2vif